Clinical Trials Logo

Chronic Pruritus clinical trials

View clinical trials related to Chronic Pruritus.

Filter by:
  • None
  • Page 1

NCT ID: NCT05678309 Not yet recruiting - Pruritus Clinical Trials

Establishment of a Patient Library in Patients With Pruritus Sine Materia

PRURITHEQUE
Start date: April 1, 2023
Phase:
Study type: Observational [Patient Registry]

Very little is currently known about the pathophysiology of pruritus sine materia according to the etiology. The creation of this cohort should make it possible to improve our clinical and biological knowledge according to the etiology, by collecting blood, skin, feces, and clinical data.

NCT ID: NCT05038982 Completed - Pruritus Clinical Trials

Efficacy of Abrocitinib for Reducing Pruritus in Adults With Prurigo Nodularis and Chronic Pruritus of Unknown Origin

Start date: September 9, 2021
Phase: Phase 2
Study type: Interventional

The primary objective is to assess the efficacy, safety, and tolerability of Abrocitinib for the treatment of Prurigo Nodularis (PN) or Chronic Pruritus of Unknown Origin (CPUO) in patients experiencing moderate to severe pruritus.

NCT ID: NCT04949893 Completed - Chronic Pruritus Clinical Trials

Causes of Chronic Pruritus

PRURISINE
Start date: May 2, 2019
Phase:
Study type: Observational

The aim of this study is to include all patients followed between 2008 and 2018 in order to analyze the etiologie of the chronic pruritus

NCT ID: NCT04693195 Completed - Atopic Dermatitis Clinical Trials

A Multiple-Dose Study of BLU-5937 in Chronic Pruritus Associated With Atopic Dermatitis

BLUEPRINT
Start date: December 9, 2020
Phase: Phase 2
Study type: Interventional

This is a multicenter, randomized, double-blind, placebo-controlled, parallel design study of BLU-5937 for the treatment of chronic pruritus in adult subjects with atopic dermatitis (AD).

NCT ID: NCT03751111 Completed - Chronic Pruritus Clinical Trials

Treatment of Chronic Itch in Patients Under Arsenic Exposure With Sublingual Naloxone

Start date: February 13, 2019
Phase: Phase 1/Phase 2
Study type: Interventional

The purpose of this study is to assess the efficacy and safety of sublingual naloxone in the treatment of chronic itch in patients under arsenic exposure.

NCT ID: NCT02672579 Completed - Chronic Pruritus Clinical Trials

Study of Kids Itch Severity (SKIS)

SKIS
Start date: May 2015
Phase:
Study type: Observational

This purpose of this study is to validate two measures of chronic itching in kids: itch severity (ItchyQuant) and the impact on their quality of life (ItchyQoL).

NCT ID: NCT01951274 Completed - Chronic Pruritus Clinical Trials

VPD-737 for Treatment of Chronic Pruritus

Start date: October 15, 2013
Phase: Phase 2
Study type: Interventional

A study of a several doses of a novel treatment for chronic itch compared to placebo for patients whose condition has not responded to other treatments